Colon delivery of 5 – Fluoro uracil using cross-linked chitosan microspheres coated with eudragit S 100

Authors

  • Nayak Shivani Novel Drug Delivery Laboratory, Center of Relevance and Excellance in NDDS, Pharmacy department, The M.S.University of Baroda, Vadodara-390 001, Gujarat, India.
  • Patel Hetal Novel Drug Delivery Laboratory, Center of Relevance and Excellance in NDDS, Pharmacy department, The M.S.University of Baroda, Vadodara-390 001, Gujarat, India.
  • Kesarla Rajesh Center for Nanomedicine, ISF College of Pharmacy, G.T.Road, Moga-142 001, Punjab, India
  • Rayasa Ramachandra Murthy Center for Nanomedicine, ISF College of Pharmacy, G.T.Road, Moga-142 001, Punjab, India

Keywords:

5-FU, colon-targeting, chitosan, microspheres, Eudragit S-100

Abstract

5-Fluorouracil though recommended as a chemotherapeutic agent for colorectal cancer, suffers from severe systemic toxicity and so needs site-specific delivery. Objective of present investigation is to design slow release enteric coated solid formulations to avoid drug release in stomach and upper small intestine but slowly to build up required drug concentration in the colon. Chitosan microspheres were prepared by emulsification method using gluteraldehyde as cross linking agent. The microspheres were then coated with Eudragit S – 100 by emulsion solvent evaporation method. The coated microspheres were characterized for particle size, entrapment efficiency and surface characteristics. In-vitro drug release profile was studied by changing pH media as per USP protocol and the data was subjected to kinetic interpretations. The optimized microspheres showed particle size in the range of 62 to 65 μm with 65 ± 2% drug entrapment. Eudragit coated chitosan microspheres showed particle size increase upto 390 ± 2 μm with nearly spherical shape and smooth surface. In vitro drug release profile of uncoated microspheres was typical like conventional dosage forms with 38 %, 62 % and 88 % drug release at the end of 2 hrs, 6 hrs and 10 hrs respectively. Coated microspheres showed no drug release in SGF (2hrs), negligible release (8 %) in 6hrs but substantial release of 95% in 24 hours in simulated colon media. Drug distribution in GI following oral administration of coated microspheres in wistar rats showed 84% of the drug accumulation in colon.

References

Diasio RB, Harris BE. Clinical

Pharmacology of 5 – fluorouracil. Clin

Pharmacokinet 1989;16:215–237.

Meissner Y, Lamprecht A. Alternative drug

delivery approaches for the therapy of

inflammatory bowel disease. J Pharm Sci

;97(8):2878-2891.

Jain SK, Jain A, Gupta Y, Ahirwar M.

Design and Development of Hydrogel

Beads for Targeted Drug Delivery to the

Colon. AAPS Pharm Sci Tech

;8(3):Article 56.

Friend DR. Colon specific drug delivery,

Adv Drug Del Rev 1991;7(1):149-199.

Makhlof A, Tozuka YT. pH-Sensitive

nanospheres for colon-specific drug

delivery in experimentally induced colitis

rat model. Eur J Pharmaceut Biopharm

;72(1):1-8.

Controlled drug delivery. In: Bruck SD,

editor. Vol. 2. CRC Press; 1982;p. 190.

Uekama M, Horikawa T, Yamanaka M,

Hiramaya F. Peracylated b-cyclodextrins as

novel sustained release carries for a water

soluble drug, molsidomine. J Pharm

Pharmacol 1994;46:714-717.

Patel HK, Nagle A, Murthy R.

Characterization of calcium alginate beads

of 5-fluorouracil for colon delivery. Asian J

Pharm 2008;2:241-5.

Mooter GVD, Samyn C, Kinget R. In vivo

evaluation of a colon – specific drug

delivery system: An absorption study of

Theophylline from capsules coated with

Azo polymers in Rats. Pharm Res

;12(2):244 – 47.

Thanoo BC, Sunny MC, Jayakrishnan A.

Cross-linked chitosan microspheres:

preparation and evaluation as a matrix for

the controlled release of pharmaceuticals. J

Pharm Pharmacol 1992;44:283-286.

Gohel MC, Amin AF, Studies in the

preparation of diclofenac sodium

microspheres by emulsion solvent

evaporation technique by response surface

analysis. Ind J Pharm Sci 1999;61(1):48-53.

Paharia A, Yadav AK, Rai G, Jain SK,

Pancholi SS, Agrawal GP. Eudragit-coated

Pectin Microspheres of 5-Fluorouracil for

Colon Targeting. AAPS Pharm Sci Tech

;8(1):E1:E7:Article 12.

Adel NM, Shirazi FH, Cripps CM, Shereeni

V, Molepo MJ, Obrocea M, Diedre R,

Bates S, Fry D, Stewart DJ, Goel R. An

HPLC method for the measurement of 5-

fluorouracil in human plasma with a low

detection limit and a high extraction yield.

Int J Mol Med 2002;10(4):513-6.

Wan NWS, Endud CS, Mayamar R. Effect

of crosslinking agents on chitosan

microspheres in controlled release of

diclofenac sodium. Reac Func Polymers

;50:181-190.

Gonçalves VL, Laranjeira MCM, Fávere

VT, Pedrosa RC. Effect of crosslinking

agents on chitosan microspheres in

controlled release of diclofenac sodium.

Polímeros: Ciência e Tecnologia

;15(1):6-12.

Downloads

Published

2011-06-30

How to Cite

Nayak Shivani, Patel Hetal, Kesarla Rajesh, & Rayasa Ramachandra Murthy. (2011). Colon delivery of 5 – Fluoro uracil using cross-linked chitosan microspheres coated with eudragit S 100. International Journal of Drug Delivery, 3(2), 260268. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/75

Issue

Section

Original Research Articles